Nocturnal leg cramps
Drug Safety Update
November 2017: Quinine: reminder of dose-dependent QT-prolonging effects; updated medicine interactions.
December 2014: Quinine: not to be used routinely for nocturnal leg cramps.
Although patient response may vary, overall efficacy is modest, the frequency of nocturnal leg cramps is reduced by about 25% in ambulatory patients - around one episode a week difference.
The MHRA advises that quinine is not a routine treatment for nocturnal leg cramps and should only be used if cramps cause regular disruption of sleep. Consider quinine only when cramps are very painful or frequent; when other treatable causes of cramp have been ruled out, and when non-pharmacological measures have not worked, (e.g. passive stretching exercises). After an initial trial of 4 weeks, treatment should be stopped if there is no benefit.
Initially patients should be monitored closely for adverse effects as well as benefit. Treatment should be interrupted at 3-monthly intervals to assess the need for further quinine. In patients taking quinine long-term, a trial discontinuation may be considered.
Please note that quinine bisulphate 300mg is approximately equivalent to quinine sulphate 200mg, so the salt should always be specified.
| Pack |
|---|
| 28 tablet (2 x 14 tablets) |
| Pack |
|---|
| 28 tablet (2 x 14 tablets) |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary
